322 related articles for article (PubMed ID: 26026287)
41. Acidosis induces hyperpermeability in Caco-2BBe cultured intestinal epithelial monolayers.
Menconi MJ; Salzman AL; Unno N; Ezzell RM; Casey DM; Brown DA; Tsuji Y; Fink MP
Am J Physiol; 1997 May; 272(5 Pt 1):G1007-21. PubMed ID: 9176208
[TBL] [Abstract][Full Text] [Related]
42. Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays.
Brayden DJ; Stuettgen V
Eur J Pharm Sci; 2021 Apr; 159():105737. PubMed ID: 33524502
[TBL] [Abstract][Full Text] [Related]
43. Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae.
Maher S; Heade J; McCartney F; Waters S; Bleiel SB; Brayden DJ
Int J Pharm; 2018 Mar; 539(1-2):11-22. PubMed ID: 29341916
[TBL] [Abstract][Full Text] [Related]
44. Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization.
McCall IC; Betanzos A; Weber DA; Nava P; Miller GW; Parkos CA
Toxicol Appl Pharmacol; 2009 Nov; 241(1):61-70. PubMed ID: 19679145
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the Caco-2 monolayer as a model epithelium for iontophoretic transport.
Leonard M; Creed E; Brayden D; Baird AW
Pharm Res; 2000 Oct; 17(10):1181-8. PubMed ID: 11145222
[TBL] [Abstract][Full Text] [Related]
46. Alpha-Melanocyte Stimulating Hormone Protects against Cytokine-Induced Barrier Damage in Caco-2 Intestinal Epithelial Monolayers.
Váradi J; Harazin A; Fenyvesi F; Réti-Nagy K; Gogolák P; Vámosi G; Bácskay I; Fehér P; Ujhelyi Z; Vasvári G; Róka E; Haines D; Deli MA; Vecsernyés M
PLoS One; 2017; 12(1):e0170537. PubMed ID: 28103316
[TBL] [Abstract][Full Text] [Related]
47. AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression.
Sun X; Yang Q; Rogers CJ; Du M; Zhu MJ
Cell Death Differ; 2017 May; 24(5):819-831. PubMed ID: 28234358
[TBL] [Abstract][Full Text] [Related]
48. Glutamine supports recovery from loss of transepithelial resistance and increase of permeability induced by media change in Caco-2 cells.
Li N; DeMarco VG; West CM; Neu J
J Nutr Biochem; 2003 Jul; 14(7):401-8. PubMed ID: 12915221
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Sucrose Laurate as an Intestinal Permeation Enhancer for Macromolecules: Ex Vivo and In Vivo Studies.
McCartney F; Rosa M; Brayden DJ
Pharmaceutics; 2019 Oct; 11(11):. PubMed ID: 31683652
[TBL] [Abstract][Full Text] [Related]
50. Effects of luminal thymol on epithelial transport in human and rat colon.
Kaji I; Karaki S; Kuwahara A
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1132-43. PubMed ID: 21372164
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of intestinal absorption of macromolecules by spermine in rats.
Sugita Y; Takao K; Toyama Y; Shirahata A
Amino Acids; 2007 Aug; 33(2):253-60. PubMed ID: 17653818
[TBL] [Abstract][Full Text] [Related]
52. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Apr; 354(1-2):126-34. PubMed ID: 18206325
[TBL] [Abstract][Full Text] [Related]
53. Protective effects of lactoferrin against intestinal mucosal damage induced by lipopolysaccharide in human intestinal Caco-2 cells.
Hirotani Y; Ikeda K; Kato R; Myotoku M; Umeda T; Ijiri Y; Tanaka K
Yakugaku Zasshi; 2008 Sep; 128(9):1363-8. PubMed ID: 18758152
[TBL] [Abstract][Full Text] [Related]
54. Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity.
Jevprasesphant R; Penny J; Attwood D; McKeown NB; D'Emanuele A
Pharm Res; 2003 Oct; 20(10):1543-50. PubMed ID: 14620505
[TBL] [Abstract][Full Text] [Related]
55. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
[TBL] [Abstract][Full Text] [Related]
56. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
[TBL] [Abstract][Full Text] [Related]
57. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
58. Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models.
Zornoza T; Cano-Cebrián MJ; Nalda-Molina R; Guerri C; Granero L; Polache A
Eur J Pharm Sci; 2004 Aug; 22(5):347-56. PubMed ID: 15265504
[TBL] [Abstract][Full Text] [Related]
59. The mycotoxin patulin increases colonic epithelial permeability in vitro.
Mohan HM; Collins D; Maher S; Walsh EG; Winter DC; O'Brien PJ; Brayden DJ; Baird AW
Food Chem Toxicol; 2012 Nov; 50(11):4097-102. PubMed ID: 22906760
[TBL] [Abstract][Full Text] [Related]
60. In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs.
Imai T; Sakai M; Ohtake H; Azuma H; Otagiri M
Pharm Res; 1999 Jan; 16(1):80-6. PubMed ID: 9950283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
